Quick Takeaways: Why It Matters? Petwealth’s partnership with Kennel Connection aims to embed molecular (PCR) health screening directly into boarding, daycare, grooming and training facilities- places pets already visit regularly- so owners get earlier, actionable hea...
Quick Takeaways: Why It Matters? IDEXX’s Catalyst proBNP brings a well‑known heart‑disease blood test into the vet clinic with results in minutes, so vets can spot hidden heart problems, decide quickly in breathing emergencies, and monitor patients without waiting day...
Quick Takeaways: Why It Matters? By unifying Saladpet and Dogibogi under Kinfora, LIMPID should improve user retention, cross-sell higher-margin nutrition products, and gather denser longitudinal data that can support its “digital twin” ambition and future AI biomarker work in chronic dise...
Quick Takeaways: Why It Matters? The deal broadens PetIQ’s product mix into a higher-value mobility category that can be cross-sold through retail, e-commerce and distribution channels, potentially increasing average basket size and strengthening PetIQ’s positioning as a branded pet health...
Quick Takeaways: Why It Matters? By terminating the PrecisePRP arrangement with VetStem, PetVivo removes outstanding invoices, royalties and milestone overhangs from a non-core product line, which should simplify the story for investors and management while freeing attention and capital fo...
Quick Takeaways: Why It Matters? Zoetis’s Portela launch should expand the feline OA market by turning a hard-to-manage, underdiagnosed condition into a more actionable treatment segment, especially because the therapy offers a three-month injectable option that is easier for owners to kee...
Quick Takeaways: Why It Matters? Zoetis’s launch of Lenivia (izenivetmab) in Canada and the EU introduces the first long-acting monoclonal antibody for canine osteoarthritis that binds a different NGF site than existing anti‑NGF therapies, offering up to three months of pain relief from a ...
Quick Takeaways: Why It Matters? PetVivo’s new study shows that a single intra-articular Spryng injection with OsteoCushion technology can improve pain and function in dogs with stifle osteoarthritis and suspected cranial cruciate disease. While the authors call for larger studies with obj...
Quick Takeaways: Why It Matters? Akston could emerge as a serious competitor in the fast-growing anti‑NGF OA segment that Zoetis currently leads with its once‑monthly monoclonal. Because Akston’s Ambifect approach stimulates sustained endogenous anti‑NGF antibody responses, AKS‑548d remain...
Quick Takeaways: Why It Matters? Wuffes’ PetSmart rollout is a big distribution milestone that moves it from DTC success into mainstream retail scale, giving the brand national shelf visibility, stronger consumer trust, and access to PetSmart’s 1,300+ U.S. stores plus its e-commerce traffi...
